HALO Growth 100 · Sector S2
Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly | NAM | 1432.29 | +1.44% | +1.63% | +21.11% | +17.37% | +44.94% | +55.43% | USD |
| REGN | Regeneron | NAM | 916.06 | -0.42% | -5.89% | +20.09% | +14.80% | +26.63% | +39.66% | USD |
| AMGN | Amgen | NAM | 465.23 | +0.00% | +0.86% | +11.41% | +11.79% | +39.39% | +47.34% | USD |
| VRTX | Vertex Pharma | NAM | 547.89 | -0.54% | +3.23% | +8.07% | +4.22% | +22.22% | +33.80% | USD |
| GXI.DE | Gerresheimer | EUR | 31.22 | +0.71% | -3.04% | +7.29% | +16.06% | +24.28% | +28.58% | EUR |
| ZEAL.CO | Zealand Pharma | EUR | 249.60 | +1.88% | +6.58% | +6.30% | -26.85% | -25.71% | -47.68% | DKK |
| NVO | Novo Nordisk | EUR | 40.70 | -1.64% | +1.27% | +5.50% | -12.27% | -13.40% | -7.63% | USD |
| VKTX | Viking Therapeutics | NAM | 28.66 | -1.14% | +9.85% | +1.13% | -15.76% | -8.49% | -22.06% | USD |
| NTRA | Natera | NAM | 311.98 | -2.62% | -19.72% | -21.57% | -1.26% | +52.77% | +56.33% | USD |
| ILMN | Illumina | NAM | 214.91 | -2.66% | -9.78% | -22.32% | +11.40% | +47.50% | +76.30% | USD |